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Background: Network-based approaches for the analysis of large-scale genomics data have become well established.
Biological networks provide a knowledge scaffold against which the patterns and dynamics of ? omics? data can be
interpreted. The background information required for the construction of such networks is often dispersed across a
multitude of knowledge bases in a variety of formats. The seamless integration of this information is one of the main
challenges in bioinformatics. The Semantic Web offers powerful technologies for the assembly of integrated knowledge
bases that are computationally comprehensible, thereby providing a potentially powerful resource for constructing
biological networks and network-based analysis.
Results: We have developed the Gene eXpression Knowledge Base (GeXKB), a semantic web technology based
resource that contains integrated knowledge about gene expression regulation. To affirm the utility of GeXKB we
demonstrate how this resource can be exploited for the identification of candidate regulatory network proteins. We
present four use cases that were designed from a biological perspective in order to find candidate members relevant
for the gastrin hormone signaling network model. We show how a combination of specific query definitions and
additional selection criteria derived from gene expression data and prior knowledge concerning candidate proteins
can be used to retrieve a set of proteins that constitute valid candidates for regulatory network extensions.
Conclusions: Semantic web technologies provide the means for processing and integrating various heterogeneous
information sources. The GeXKB offers biologists such an integrated knowledge resource, allowing them to address
complex biological questions pertaining to gene expression. This work illustrates how GeXKB can be used in
combination with gene expression results and literature information to identify new potential candidates that may be
considered for extending a gene regulatory network.
Keywords: Knowledge management, Knowledge representation, Semantic Systems Biology, Semantic Web, RDF,
SPARQL, Network extension, Gene expression, Transcription regulation, Protein-protein interaction, Transcription factor,
Target gene interaction, Hypothesis assessment, Gastrin biologyBackground
Cellular signaling cascades support the transmission of
information from external signals (e.g. hormones) to dis-
tinct cellular responses, for instance changes in gene
expression. Gene expression is controlled by a network
of highly interconnected proteins known as transcription
regulators [1,2]. There is a large array of transcription re-
gulators including general transcription factors, sequence-* Correspondence: martin.kuiper@ntnu.no
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unless otherwise stated.specific DNA binding transcription factors (DbTFs), va-
rious transcription co-factors and chromatin modifiers
[3,4]. Research in the field of gene expression is particu-
larly important because various aberrations of this process
have been implicated in the development of diseases, in-
cluding cancer. Consequently, the research in this field
has now generated a huge volume of information, which
is certain to grow in the years to come. However, this in-
formation and the associated data are scattered across a
multitude of resources in a variety of formats, which
makes it a challenge to obtain a comprehensive access to
all information necessary to answer questions that biolo-
gists working in this field may pose.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hypotheses against prior knowledge fundamentally relies
on efficient knowledge integration that interlinks infor-
mation and knowledge at various levels in standardized
formats, after which the best-supported hypotheses can
be selected for testing in wet-lab experiments. There-
fore, the development of technologies for knowledge in-
tegration and representation has evolved into a major
research area [5,6].
In recent years the Semantic Web has emerged as one
of the most promising solutions to high scale inte-
gration of distributed resources. The Semantic Web
initiative [7] essentially aims at transforming the current
Web into a global reasoning and semantics-driven
knowledge base. The Semantic Web is founded on a
stack of technologies such as the Resource Description
Framework (RDF) [8], RDF Schema (RDFS) [9], Web
Ontology Language (OWL) [10] and the SPARQL
Query Language (SPARQL) [11]. RDF, part of the basis
of the stack, models data as a directed graph composed
of so-called triples, each comprising two nodes (the sub-
ject and the object) connected by an edge (the predicate).
All these technologies use the Uniform Resource Identi-
fiers (URI) to identify real-world objects and concepts and
the Hypertext Transfer Protocol (HTTP) for communica-
tion. The SPARQL querying language allows for the re-
trieval of triples of interest (a sub-graph) from an arbitrary
set of RDF graphs that may reside at various locations on
the Internet.
Ontologies, though introduced to the field of know-
ledge management long before the advent of the Semantic
Web, have become an indispensable tool for practical
implementations of semantic web technologies by provi-
ding a common understanding for people and computers
alike, and may be regarded as part of the toolbox of the
Semantic Web. In the field of biomedical research, the
Open Biomedical Ontologies (OBO) Foundry [12] pro-
vides a set of guidelines to structure the coordinated de-
velopment of bio-ontologies. Bio-ontologies developed
following the guidelines of the OBO Foundry are beco-
ming widely used by the life science community. The
Gene Ontology (GO), a prominent example of this [13],
provides a unified representation of properties of genes
and their products. Furthermore, the Gene Ontology
Annotation (GOA) project [14] facilitates unambiguous
annotation of gene products with GO terms covering
molecular function, cellular component and biological
process aspects.
We are currently witnessing a growing use of semantic
web technologies for the management of biological con-
cepts and for providing a scaffold for integrating concepts
and data from disparate biological databases [15-17]. In
this vein we have developed the Gene Expression Know-
ledge Base (GeXKB), to serve the needs of researchersworking in the field of gene regulation. We were moti-
vated by the following considerations:
1. Even though SPARQL supports federated querying,
this mode presents an additional hurdle for a
biologist.
2. Querying distributed and typically very large
resources takes long execution times.
3. The currently available reasoners are still too
sluggish to be deployed on very large graphs, in
particular when rule chaining is involved.
4. The resources necessary for adequately answering
specific questions are not always found in the
available triple stores.
GeXKB accommodates the field of gene expression
regulation by seamlessly integrating the most relevant on-
tologies and databases, using semantic web technologies
(preliminary results appeared in a conference paper [18]).
GeXKB was developed in close collaboration with end
users who provided requirements and use cases. The use
cases were taken from the domain of gastrin hormone
response pathways, in particular gastrin-mediated gene
regulation, introduced below.
Use cases
Several biological questions were formulated in the
context of the gastrin response pathways. Gastrin is a
gastrointestinal peptide hormone, which, similar to
many other extracellular signals such as e.g. growth fac-
tors, plays a crucial role in both normal and pathological
processes. After binding to the Cholecystokinin 2 recep-
tor (CCK2R), gastrin triggers the activation of multiple
intracellular signaling pathways and transcription re-
gulation networks culminating in the regulation of nu-
merous genes. We previously performed an extensive
genome-wide gene expression time-series experiment
on gastrin-treated rat AR42J cells [19] (the ArrayEx-
press database [20], accession number: GSE32869). This
work allowed us to identify genome wide changes in
mRNA levels in response to gastrin, serving as an ex-
perimental reference for our study. In addition, we used
a map of gastrin responsive intracellular signaling and
transcription regulation networks, which we built pre-
viously through an exhaustive search for experimental
evidence reported in literature [21]. This map was taken
as a point of departure to identify new proteins that
should be considered as putative network extensions.
We reasoned that, given the knowledge sources inte-
grated into GeXKB, queries based on our biological
questions should yield both well established and new
gastrin response network participants. In total we deve-
loped 6 queries (identified as Q1 through Q6, see Query
formulation section) for the following four use cases:
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regulation of transcription factor CREB1
The cAMP response element binding protein 1 (CREB1)
is a specific DNA binding transcription factor. It is
known to be under the control exerted by multifarious
regulator complexes that include DbTFs, co-factors and
kinases. We were interested in retrieving an exhaustive
overview of possible regulators of CREB1.
Use case II: Identifying repressors of NFκB1 and RELA that
undergo proteasomal degradation
NFκB1 and RELA are members of the NFκB transcription
factor family known to be involved in regulating apoptosis,Figure 1 Core CCK2R network and novel candidate regulators. The co
the novel candidate regulators resulting from our queries are shown. The C
The network components in grey and the solid lines connecting them are
CCK2R DbTFs and respond to gastrin. The dotted lines represent new relat
blue pointed arrows denote ? activation or positive influence? and red bar-h
regulators identified through Q1, Q2 and Q3 are colored yellow. Candidate
candidate regulators of TCF7L2 identified through Q5 are colored orange. T
the DbTF candidates identified through Q6 are colored light red (JUN andproliferation, and immune responses [22]. Gastrin de-
pendent regulation of these transcription factors repor-
tedly is mediated through PKC and Rho GTPase signaling
cascades [23,24] (Figure 1). The activity of NFκB tran-
scription factors is under the control of a family of inhibi-
tors, known as ? inhibitors of kB? (IkB), which sequester
NFκB in the cytoplasm and thereby keep these tran-
scription factors in their inactive state [25]. Proteasomal
degradation of IkB factors results in restoration of the
active state of the NFκB and promotes its import to the
nucleus. In order to gain detailed mechanistic insights
in NFκB regulation, we were interested in retrieving
proteins that contribute to NFκB down-regulation, andre of the gastrin mediated signal transduction network (CCK2R), and
CK2R DbTFs that were targeted in our queries are colored light green.
part of the core CCK2R network and documented as regulators of the
ions identified by the queries which could be verified against literature:
eaded arrows depict ? repression or negative influence ? . CREB1 candidate
regulators of NFκB1 identified through Q4 are colored turquoise, and
he target genes shared by the CCK2R DbTFs (CREB1 and NFκB1) and
BRCA2) and their connections are shown as solid arrows.
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degradation.
Use case III: Listing components that function as repressors
for TCF7L2 and activators for NFκB1 or CREB1
DbTFs are implicated in different cellular processes in
the gastrin response signaling cascade. TCF7L2 plays a
central role in gastrin mediated cellular migration [26],
whereas NFκB1 and CREB1 are pivots of regulation of
gastrin dependent immune responses and proliferation,
respectively [27,28]. Proteins that function as repressors
for one transcription factor and activators for another
can be of potential significance for cellular decision
making.
Use case IV: Identification of genes that are shared targets
of DbTF regulators and the DbTFs described in use
cases I-III
DbTFs are central to the regulation of gene transcrip-
tion, which in turn plays a key role in determining gene
expression levels. Often, several DbTFs act together in
the regulation of transcription of a specific gene. To
enhance our understanding of mechanisms involved in
gastrin mediated cellular responses we were interested
in retrieving shared target genes of CREB1, NFKB1,
TCF7L2 and the regulators of these DbTFs.
Methods
GeXKB construction
GeXKB was conceived as an easily extensible knowledge
base consisting of a core to which any number of optional
resources could be easily added (See Results/GeXKB, for a
detailed description of the contents).
The construction involves 1) the development of three
application ontologies that form the core of GeXKB, 2)
conversion of optional resources to RDF, 3) uploading
the ontologies and the optional resources to a triple
store to make them accessible through a SPARQL end-
point, 4) inferring and adding to the store new triples
supported by the explicitly asserted ones to increase the
power and flexibility in querying. The 4 steps in detail:
Step 1: The GeXKB ontologies are generated by an
automated data integration pipeline (Figure 2) that relies
on the ability to programmatically manipulate ontologies
with the ONTO-PERL API [29]. This pipeline allows the
ontologies to be easily updated. First, a concise upper
level ontology (ULO) is assembled from terms imported
from other ontologies (Figure 3). Next, fragments of the
GO ontology, a fragment of the MI ontology [30] and
the Biorel [31] ontology are linked to the ULO. The result
is three ontologies referred to as the seed ontologies. Fur-
ther sets of proteins are retrieved from the Gene Ontology
Annotation files by association with the Biological Process
terms present in each of the seed ontologies. These sets ofproteins (referred to as ?core? proteins) are used subse-
quently as a basis to select by association additional pro-
teins from IntAct protein-protein interactions [32], KEGG
pathways [33] and binary orthology relations as predicted
by the orthAgogue utility [34], a high performance C++
implementation of OrthoMCL [35]. Finally, protein modi-
fications, basic gene information and associations with
Cellular Component and Molecular Function terms from
GO are added from UniProtKB [36], NCBI Entrez [37]
and the Gene Ontology Annotations, respectively (see
Additional file 1 for the full set of term types in GeXKB).
The pipeline finally outputs the three application onto-
logies in the OBO [38] and RDF [8] formats.
The mappings provided by UniProtKB [39] are used for
inter-conversion of IDs and names in the core GeXKB. En-
tities which cannot be mapped in this way are omitted. All
the identifiers in GeXKB ontologies are in the form name-
Space:ID in the OBO files and nameSpace_ID in the RDF
files. Original IDs are used throughout if available. IDs for
modified residues are constructed by replacing spaces with
underscores in the corresponding names. Original name
spaces are used for the imported ontological terms.
The only ontological terms constructed specifically for
this project are GeXO:0000001, ReXO:0000001 and ReTO:
0000001. These three terms are modelled by analogy with
the term ?cell cycle process? in GO. The name spaces used
for other term types are as follows: ?UniProtKB? for protein
terms, ?KEGG? for pathway terms, ?NCBIGene? for gene
terms, ?NCBITaxon? for taxon terms, ? SSB? for modified re-
sidue terms and ? intact? for protein-protein interactions
terms. Apart from the generic subsumption and parto-
nomy, 10 more specific relation types are used to construct
GeXKB ontologies (see Additional file 1).
Step 2: The optional resources are converted to RDF
with the use of simple Perl scripts. Documented infor-
mation about the functional interaction of DbTFs with
their target genes is added from: a) the PAZAR database
[40], an open source framework that serves as an um-
brella to bring together datasets pertaining to transcrip-
tion factors and regulatory sequence annotations; b) the
Human Transcriptional Regulation Interactions (HTRI)
database [41], an open-access database that serves as a re-
pository for experimentally verified human transcription
factor - target gene interactions; c) TFactS [42], a database
that catalogs curated transcription factor - target gene in-
teractions; and d) TFcheckpoint [43], a database that com-
piles curated information on human, rat and mouse DbTF
candidates from many different database resources. As
described above (step 1), entities from these resources
are filtered based on the ID mapping file provided by
UniprotKB. (Additional file 1 for the number of DbTFs
and target genes per resource).
Step 3: All the RDF files are uploaded to an instance
of the OpenLink Virtuoso data storage engine [44] as
Figure 2 The data integration pipeline. The integration starts by generating an Upper Level Ontology, which is then linked with the different
ontologies: GO (Biological Process, Molecular Function and Cellular Component fragments), the MI ontology and the Biorel ontology, forming a
seed ontology. Mouse, human and rat-specific data are integrated from Gene Ontology Annotation files and IntAct. Next, these species-specific
ontologies are merged and additional data is integrated including protein information (UniProt), pathway annotations (KEGG), basic information
for genes (NCBI) and orthology relations for proteins (orthAgogue). The final ontology is available in OBO and RDF formats.
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Figure 3 Upper Level Ontology (ULO). The ULO was developed on the basis of terms imported from other ontologies. The three application
ontologies have structurally identical ULOs, differing only in the sub-domain specific terms. The figure illustrates the ULO structure of GeXO.
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graphs are made accessible by SPARQL via a web page
query form which offers a collection of pre-assembled
queries to aid novice users [45].
Step 4: The inference process is performed by using
the SPARQL update language (SPARUL) [46] as de-
scribed in [31]. The graphs containing pre-computed in-
ferences is suffixed with ? -tc ? (e.g. ReTO-tc, where ? tc ?
stands for total closures).
Query formulation
All biological questions for the use cases (see section:
Use cases) were converted to SPARQL queries targeting
the Homo sapiens information in GeXKB.
Use case I
To address use case I, three queries were formulated (Q1-
Q3, Additional file 2) that return positive and negative re-
gulators and chromatin modifiers of CREB1 (UniProt ac-
cession: P16220, commonly referred to as ? CREB? ). Query
Q1 retrieves proteins that are involved in the activation of
CREB1. To achieve this, the query combined different
terms that suggest the activation of CREB1. First of all, we
used the ReTO and ReTO-tc graphs as default graphs for
the queries as they are suitable to query nuclear transcrip-
tional processes. Next, the GO terms positive regulation of
CREB transcription factor activity (GO:0032793) and cAMP
response element binding protein binding (GO:0008140)
were included in the query. These terms suggest direct
association with the process of regulating CREB1. Ad-
ditionally, the term direct interaction (MI:0407) was in-
cluded in the query to retrieve proteins that interact
directly with CREB1. Then, to widen the breadth of the
query, the broader GO term positive regulation of se-
quence-specific DNA binding transcription factor activity(GO:0051091) was included. However, in this case only
proteins that have a physical association (MI:0914) with
the CREB1 protein were considered, thus reducing the
number of false positives (see Figure 4).
Similarly, Q2 retrieves proteins involved in the repres-
sion of CREB1 protein. For this query, proteins associated
with biological process terms negative regulation of CREB
transcription factor activity (GO:0032792) and negative
regulation of sequence-specific DNA binding transcription
factor activity (GO:0043433) were used.
The query Q3 specifies chromatin modifiers that are
involved in the regulation of CREB1. It retrieves the
union of proteins associated with the molecular function
terms histone acetyltransferase (GO:0004402) and his-
tone deacetylase (GO:0004407) activity that are involved
in the biological process regulation of sequence-specific
DNA binding transcription factor activity (GO:0051090),
and are interacting with the CREB1 protein. Other than
providing putative network components, these queries
also serve to demonstrate the utility of targeting rela-
tions obtained through the inferencing process. By using
the ReTO-tc graph, we were able to include implicit
knowledge statements in the query output, meaning
ontology term relationships not directly annotated to
proteins, but linked to them through the inferencing
process (see section: GeXKB construction).
Use case II
Use case II is represented by Q4, which was constructed
similar to the previous queries by using a combination of
terms. First, the GO term negative regulation of NFκB
transcription factor activity (GO:0032088) was chosen as
the central term, as this would retrieve all proteins anno-
tated as negative regulators of NFκB1 and RELA. Next,
GeXKB was explored to identify terms that suggested an
Figure 4 Conceptual model of Q1. The figure displays the different concepts, ontology terms and relationships that together form a graph that
was used as a SPARQL query to find matching patterns in GeXKB. The query specifies proteins that A) exhibit positive regulation of CREB transcription
factor activity (GO:0032793); B) exhibit positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091) and are linked to
the CREB1 protein through an association (MI:0914); C) are linked to the CREB1 protein through a direct interaction (MI:0407); and D) have function
cAMP response element binding protein binding (GO:0008140).
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were identified: ubiquitin ligase complex (cellular com-
ponent: GO:0000151), ubiquitin binding (molecular func-
tion: GO:0043130), ubiquitination reaction (interaction
type: MI:0220), and ubiquitin mediated proteolysis (KEGG
pathway: ko04120). The SPARQL union construct was
used to formulate a combination of the central term and
the additional set of terms.
Use case III
Query Q5 represents use case III, but for this query
no terms specifically suggesting negative regulation of
TCF7L2 were found (contrary, for instance, to Q4 where
a specific GO term was used to retrieve negative regula-
tors of NFκB protein). Hence, Q5 was formulated by
using generic terms that indicated a dual role of pro-
teins. Consequentially, Q5 retrieves proteins that interact
with the TCF7L2 protein (UniProt accession: Q9NQB0)
and are further annotated with the terms negative regu-
lation of sequence-specific DNA binding transcription
factor activity (GO:0043433), and positive regulation of
sequence-specific DNA binding transcription factor ac-
tivity (GO:0051091).
Use case IV
Use case IV was investigated by first identifying DbTFs
among the results obtained for queries Q1, Q2, Q4 and
Q5. This was done by extending these queries and using
the TFcheckpoint graph for DbTF identification.
Next, Q6 was formulated to retrieve from the TFactS,
PAZAR and HTRIdb graphs target genes shared betweenthe query DbTFs (CREB1, NFKB1 and TCF7L2) and the
DbTFs identified above.
Results
GeXKB
GeXKB utilizes the knowledge representation features of-
fered by RDF and builds on previous efforts to use seman-
tic web technologies for the integration of knowledge
[47-51]. GeXKB supports the three model organisms
Homo sapiens, Mus musculus and Rattus norvegicus. Cur-
rently GeXKB is composed of three application ontologies
integrating only primary resources which are regularly up-
dated; four secondary resources containing DbTF-target
gene relations (not necessarily up to date); and ID map-
pings to support querying.
The knowledge base is hosted by a triple store and can
be queried with SPARQL.
To satisfy the requirements of end users, three nested ap-
plication ontologies (see Figure 5) were developed: the
Gene eXpression Ontology (GeXO, 89735 terms, 455859
relationships); the Regulation of Gene eXpression Ontology
(ReXO, 77610 terms, 382721 relationships); and the Regu-
lation of Transcription Ontology (ReTO, 70222 terms,
341963 relationships). All the three ontologies are 18 levels
deep and ? is_a? complete. These application ontologies are
knowledge bases in their own right since, unlike domain
ontologies, they include not only ontological terms but
experimental data as well (see below). This unique design
allows for fast execution of even complex queries. The
availability of three ontologies varying in breadth allows to
easily define the specificity while querying.
Figure 5 GeXKB ontologies. The illustration shows the layout of the
nested GeXKB ontologies (GeXO, ReXO and ReTO).The blue nodes
represent the upper level ontology (ULO), the common root of the
three ontologies. The black and red edges depict ? is_a? and ?part_of?
relations, respectively. The three ontologies cover an increasingly wide
domain. Each GO sub-domain term (e.g. GO:0010467; denoting ?gene
expression? ) and its descendants are linked to the ULO as a subclass of
? Biological Process? represented by the ?dotted edges? .
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Ontology (ULO), which is built ? on the fly ? . It is not
available as an independent artifact in contrast with
upper level ontologies like BFO, and it solely serves to
? glue ? together the various components within an appli-
cation ontology (Figure 3). The ULO was developed on
the basis of SIO [52] (14 terms). A small number of ad-
ditional terms (1 or 2 per ontology) from BioPAX [53],
ChEBI [54], IAO [55], PSI-MOD [56], and OBI [57] are
used to provide an interface between the SIO terms and
the data, when needed. The ULO is merged with the GO
through sub-domain-specific fragments of the Biological
Process branch, and the complete Molecular Function
and Cellular Component branches. More specifically, the
GO terms ?gene expression? (GO:0010467), ? regulation of
gene expression? (GO:0010468) and ? regulation of tran-
scription, DNA dependent? (GO:0006355) with all their
descendants were imported into GeXO, ReXO and ReTO,respectively. Additionally, the molecular interaction data
is supported by the ? interaction type? branch of the Mo-
lecular Interaction (MI) ontology [30]. The Biorel onto-
logy [31], an extension of the Relational Ontology [58], is
included to provide additional vocabulary to logically link
entities with relation attributes such as transitivity, refle-
xivity, subsumption, and priority over subsumption.
The GeXKB ontologies are protein-centric, and they
are populated with proteins from GOA, IntAct, KEGG,
and orthology relations by the filtering and aggregation
procedure described in the Methods section. The essen-
tial information available about proteins includes GOA
associations, IntAct protein-protein interactions, KEGG
pathways, protein modifications, orthology relations and,
when available, the corresponding genes (see Additional
file 1 for the number of different term types). Gene
terms are present in the ontologies only if UniProtKB
provides a reference to NCBI Entrez, and consequently
the number of gene terms in the ontologies is conside-
rably lower compared to the number of protein terms
(Additional file 1).
Although RDF is efficient in integrating data, it has
limited expressivity and it was not conceived to perform
inferencing tasks. In GeXKB this limitation is partially
overcome by the use of a semi-automated reasoning
approach developed in [31]. This approach allows the in-
ference of new relationships on the basis of relationships
explicitly asserted in GeXKB, based on five inference
rules, namely reflexivity, transitivity, priority over the
subsumption relation, superrelations and compositions
[59]. The application of this procedure has resulted in
approximately a 7 fold increase in the number of triples.
A major effort of the Semantic Web community aspires
to make resources available as part of the Linked Data
cloud [60]. We have taken initial steps towards making
the GeXKB resource Linked Data-compatible, therefore
we re-use original IDs for all entities in GeXKB and we
use a common namespace (http://www.semantic-systems-
biology.org) for all URIs. This solution combines the bene-
fits of faster query execution and familiarity of the IDs for
users. For instance, GeXKB can be queried using NCBI
Gene IDs or UniProt accessions to retrieve information
pertaining to a gene or protein of interest.
Use cases
The results returned for uses cases I through III were in-
vestigated for their relevance to the gastrin response net-
work [21] by categorizing them into two disjoint sets: a)
proteins that have already been documented as members
of the gastrin response network, and b) potential novel
components of the gastrin response network. Within the
latter a subset of regulators responsive to gastrin, re-
ferred to as b1 below, was identified on the basis of tran-
scriptomic data from a 14h time series gastrin response
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fined ? proteins known to be responsive to stimuli other
than gastrin, and those not known, designated b1i and
b1j respectively. The purpose of this classification was to
prioritize the putative components. For instance, b1i pro-
teins were given higher priority as new putative mem-
bers of the gastrin response network members due to
the available evidence from literature, whereas proteins
in category b1j are still potentially interesting for future
laboratory work, but with a lower priority. Finally, in use
case IV the results returned for Q6 were assessed based
on whether the genes regulated by the DbTFs in the
query are expressed in the AR42J cell line and whether
their expression changed in response to gastrin stimula-
tion (see Figure 6). The six SPARQL queries and the re-
sults of use cases I - III are available in the Additional
files 2 and 3 respectively.
All queries combined returned 148 putative regulators
and 20 target genes. Queries Q1, Q3, Q4 and Q5 were
launched against RDF graphs containing inferred triples
(the tc graphs, see Methods). Q1 returned 37 proteins,Figure 6 Result evaluation. The flowchart illustrates the evaluation of the
for use cases I, II and III were first classified based on their presence in the
group b were further evaluated based on evidence of gastrin induced regu
on literature evidence implicating them to respond to stimuli other than g
(b1j). Proteins qualifying both as b1 and b1i were considered to be the mos
returned for use case IV were evaluated for their expression in the AR42J c
Genes that satisfied both criteria were prioritized as putative network mem24 of them obtained by inferencing; Q4 returned 32 pro-
teins with 17 proteins resulting from inferencing. In con-
trast, the results produced by Q3 and Q5 were solely
based on the inferred triples, and yielded 21 and six pro-
teins, respectively. Table 1 shows the breakdown of the
number of proteins and genes returned for the six
queries.
Considering the relevance categories described above,
the 110 proteins identified in use case I include 52 pro-
teins qualified as b1, 16 proteins as b1i and 36 proteins as
b1j (Additional file 3). Similarly, use case II yielded 32 pro-
teins, 23 of which belonging to b1, 12 to b1i and 11 to b1j
(Additional file 3). Use case III resulted in six proteins; five
of them are members of b1i (Additional file 3). Finally, use
case IV yielded 18 potential regulators of CREB1, three of
NFKB1 and two of TCF7L2; all of them are likely DbTFs,
based on the TFcheckpoint data (Additional file 3). These
regulator proteins were subsequently used in Q6 from use
case IV to identify target genes that they share with
CREB1, NFKB1 or TCF7L2. This query yielded 20 target
genes (19 unique target genes) (Table 2), and were furtherresults returned for the use cases I through IV. The proteins retrieved
CCK2R map, constituting two groups a and b. The proteins under
lation constituting sub-group b1. Proteins in b1 were prioritized based
astrin (b1i ), and proteins not reported to be responsive to other stimuli
t promising new putative network members. Similarly, the target genes
ell system and whether these target genes were gastrin responsive.
bers.
Table 1 SPARQL query results
Use case I Use case II Use case III Use case IV
Q1 Q2 Q3 Q4 Q5 Q6
Asserted components 13 52 - 15 - 20
Inferred components 24 - 21 17 6 n/a
Intersection 3 0 0 0 0 n/a
Total 37 52 21 32 6 20
The table shows the breakdown of results returned from the six SPARQL queries that were part of use case I - IV. Asserted components: the number of proteins
retrieved by direct statements; Inferred components: proteins retrieved by inferred statements; Union: the number of proteins retrieved by using a combination
of asserted and inferred statements in the queries; Intersection: the number of proteins that are common between asserted and inferred statements; Total: the
total number of proteins and genes retrieved by the six queries. Note: n/a ? not applicable.
Venkatesan et al. BMC Bioinformatics 2014, 15:386 Page 10 of 14
http://www.biomedcentral.com/1471-2105/15/386assessed based on 1) their expression in AR42J cells and
2) their response to gastrin induced stimulation. This
finally yielded two target genes that were considered as
valid hypotheses (see Table 2 and Figure 1).
Discussion
Network based analysis of biological data forms one of
the cornerstones of systems biology. Finding new candi-
date network components is an area of active research
[61-63]. Our objective was to demonstrate the use of
semantic knowledge bases for such network expansion
work, in order to illustrate the potential value of theTable 2 DbTF ? target gene categorisation
Novel DbTF Function CCK2RDbTF T
CREM Activator CREB1 JU
FOXP3 Repressor CREB1 IF
Repressor CREB1 IL
Repressor CREB1 B
Repressor CREB1 M
TCF7L2 Repressor CREB1 M
FOXP3 Repressor NFkB1 P
Repressor NFkB1 C
Repressor NFkB1 V
Repressor NFkB1 V
Repressor NFkB1 IF
Repressor NFkB1 IL
Repressor NFkB1 B
Repressor NFkB1 N
Repressor NFkB1 IE
Repressor NFkB1 C
Repressor NFkB1 S
Repressor NFkB1 A
SMAD3 Repressor NFkB1 M
PARP1 Activator NFkB1 B
The table lists shared target genes of the novel DbTFs and CCK2R core DbTFs, retrie
Proteins that transcriptionally regulate the core CCK2R-DbTFs (CREB1, NFkB1 and TC
regulated by the Novel DbTF indicated in column one; TGs: Target genes retrieved
CCK2R core DbTF(s); AR42J expressed: known status of target genes expression in
gastrin treatment [19].Semantic Web for biologists. Starting from a literature-
based gastrin signaling network [21] that we built pre-
viously, we chose three of its documented DNA binding
transcription factors (CREB1, NFKB1 and TCF7L2) for
the design of a set of biological questions that were for-
mulated as SPARQL queries. This allowed us to retrieve
148 candidate regulators (including the three DbTFs
from the query), and 20 shared target genes that are
likely to be regulated by both the candidate regulators
and the three query DbTFs.
Use case I was designed to identify new activators of
CREB1. The only known activator of CREB1 reported inGs AR42J expressed Gastrin responsive
N Yes Yes
NG No No
10 No No
CL2 No No
ALAT1 No No
YOD1 No No
IGR No No
XCL5 No No
CAM1 No No
WF No No
NG No No
8 No No
CL2A1 No No
FKB1 Yes Yes
R3 Yes Yes
D40LG No No
ELE No No
LOX5AP Yes Yes
MP9 No No
RCA2 Yes Yes
ved through use case I-III. Key for columns (left to right): Novel DbTFs:
F7L2); Function: Role of the regulators; CCK2R-DbTF: core CCK2R-DbTF that is
from GeXKB that are found to be common between the novel DbTFs and the
AR42J cells [19]; Gastrin responsive: known responsiveness of target genes to
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S6 Kinase 1/2 (RSK1/2, see Figure 1), a member of the
90 kDa ribosomal S6 kinase (RSK) protein family [64].
The results obtained from GeXKB suggest several other
members of the RSK family to be involved in the acti-
vation of CREB1: Ribosomal protein S6 kinase alpha-4
(RPS6KA4) and Ribosomal protein S6 kinase alpha-5
(RPS6KA5), as indicated in Additional file 3 and Figure 1.
Our literature search revealed that activation of CREB1
was indeed shown to be regulated by RPS6KA4 and
RPS6KA5 [65,66]. However, only RPS6KA4 is expressed
in AR42J cells and therefore an interesting candidate for
experimental investigation in our gastrin response model
system. Similarly, the network candidates PRKD1 (PKD1)
and PRKD2 (PKD2) were reported to play a role in CREB1
activation in other cellular responses [67,68], making them
interesting candidates for AR42J experiments since they
are expressed in this cell line (Additional file 3). Fur-
thermore, repressor candidates TCF7L2, SIRT1 and SIK1
(Additional file 3, and Figure 1) are well documented
negative regulators of the CREB1 transcriptional complex
in other experimental systems [69-71]. Proteins such as
CREB-binding protein (CREBBP, also termed CBP) which
have multiple functions depending on the context and
environments [72,73], also appear in the query result (see
Additional file 3, and Figure 1). This reflects the com-
plexity of the response with various factors interplaying
and contributing to CREB1 regulation. Taken together,
our analysis of GeXKB for information relevant to the
CCK2R network showed that gastrin mediated regulation
of CREB1 activity involves several other proteins in ad-
dition to RSK1/2, which is the only CREB1-modulator
reported so far in the literature. Rather, the cellular
outcomes mediated by CREB1 are likely to be dependent
on the interplay between different activators such as
RPS6KA4 and PRKD1/2 and repressors such as TCF7L2,
SIRT1 and SIK1, resulting in fine tuning of CREB1-
mediated gene regulatory events triggered by gastrin.
For use case II, literature screening showed that several
proteins, including NFΚBIA, CYLD, TAX1BP1, ITCH,
SIRT1 and IRAK, have been reported to undergo protea-
somal degradation and are implicated in contributing to
NFκB down-regulation (see Additional file 3 and references
therein, and Figure 1). However, in the gastrin response
signaling cascade only NFΚBIA has so far been experimen-
tally shown to be associated with negative regulation of
NFκB (reference in Additional file 3, Figure 1). The GeXKB
query result suggests additional proteins e.g. CYLD,
TAX1BP1, ITCH, SIRT1 and IRAK, that are documented
as NFκB repressors undergoing proteasomal degradation
(see Additional file 3, and Figure 1) and which can there-
fore be interesting to pursue in future experimental work.
Interestingly, in use case III the genes encoding these
six proteins (PARP1, RUNX3, CTNB1, XRCC5, XRCC6and DAXX) are all expressed in AR42J cells. Five of
these proteins (see Additional file 3 and Figure 1) have
literature evidence indicating that they function both as
activators and repressors, depending on the context. Of
these six proteins, only β-catenin (CTNNB1) has pre-
viously been shown to modulate TCF7L2 in gastrin me-
diated intracellular signaling.
In use cases I-III, protein candidates that show evi-
dence for gastrin induced regulation in the AR42J cell
line model system and other model systems (i.e. b1i)
were considered as high priority mainly due to the avail-
able literature evidence. However, we believe that further
investigation of proteins classified under the b1j category
will certainly enhance the identification of novel candi-
dates important for regulating gastrin activated DbTFs.
The result of use case IV based on the TFcheckpoint
graph suggests that regulators CREM, FOXP3, TCF7L2,
SMAD3 and PARP1 are DbTFs and share 20 target genes
that are also regulated by the well-known DbTFs CREB1
and NFkB1 (see Table 2). The genes encoding regulators
CREM, TCF7L2 and PARP1 are found to be expressed in
AR42J cells. Therefore, potential targets of any of the
AR42J expressed regulators would be of greater signifi-
cance. Further, to identify the potential target genes for ex-
perimental validation in response to gastrin, we selected
target genes that show change in gene expression during
the 14 h gastrin treatment time course in AR42J cells.
With this criterion, GeXKB provided the five candidate
target genes: JUN, NFkB1, IER3, ALOX5AP and BRCA2
(see Table 2). However, among these genes, only JUN and
BRCA2 are identified as being targets of both regulators
(CREM and PARP1, Figure 1).
The results presented in this paper demonstrate that
GeXKB can facilitate the identification of potential novel
regulators of gastrin activated DbTFs. Based on our results
with gastrin-mediated gene regulation reported in the pre-
sent paper, we believe that GeXKB can be of equal use in
any other experimental system as well. Obviously, the
more specific biological roles of the regulators and target
genes identified through GeXKB require further experi-
mental validation. Observations made through small scale
experiments such as RNAi mediated knock down of the
novel regulators or large-scale studies on knock out model
organisms should greatly enhance our current under-
standing of transcription regulation and subsequent cel-
lular outcomes. Information contained in gene expression
databases such as ArrayExpress may provide clues as to
the role of genes and products thereof. We therefore
searched for gene knockout experiments concerning the
gastrin regulation network candidates in ArrayExpress
and found evidence for candidate regulators CRTC1 and
COMD1 (see Figure 1, where these are represented by
yellow and turquoise nodes respectively): gene knock-out
experiments conducted on CRTC1 and COMD1 implicate
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(ArrayExpress accession: E-GEOD-12209) and NFkB1
(ArrayExpress accession: E-MEXP-832), respectively.
Conclusions
Our work demonstrates the level of knowledge discovery
that can be achieved when information from a broad
range of GO annotations and experimental evidence is
semantically integrated. Interlinking various data sets
using RDF provides the much needed homogeneity and
extensibility for advanced data analysis. Additionally, we
have shown the benefits of using computational infe-
rencing in building the knowledge base, as this approach
allows the retrieval of information that would otherwise
have remained implicit and hidden from querying. Our ef-
forts have involved a close collaboration between Semantic
Web specialists and biological domain experts, resulting in
novel ways for generating hypotheses and an initial assess-
ment of these hypotheses against the current understan-
ding of a regulatory network.
The utility of GeXKB is expected to grow with its fur-
ther development. The goal for future releases will be to
expand the knowledge base with additional high quality
datasets which will include relations between DbTFs and
other interactors from curated texts, partially based on
our current work on checking the full repertoire of tran-
scription factors of human, mouse and rat, and their re-
spective target genes.
Additional files
Additional file 1: GeXKB metrics. The sheets; ? Terms ? and ? Relations ?
provide summaries of the three application ontologies; Spreadsheet
? TFs-TGs ? provides metrics for the additional sources.
Additional file 2: SPARQL_queries. This file lists the 6 SPARQL queries
(Q1- Q6) formulated for use cases I ? IV.
Additional file 3: Query_results. This spreadsheet lists the results
returned for queries Q1 ? Q5. The proteins are annotated according to
the query, evaluation categories and evidence.
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